Press

Press Release • October 28, 2025

Boston Micro Fabrication Awarded U.S. Patent for Dual-Resolution Micro-Scale 3D Printing Technology

Boston Micro Fabrication (BMF), a global leader in micro-precision 3D printing solutions, today announced that the United States Patent and Trademark Office has granted U.S. Patent No. 12,420,486 B2, titled “Multi-Scale System for Projection Micro Stereolithography.” The patent covers BMF’s groundbreaking dual-resolution optical system, a key innovation behind the company’s microArch® D1025 printer.
Read More
All-About-Industries • October 15, 2025

Test Specialist Manufactures Connectors in Small Series Using 3D Printing

Technical progress requires courage - Bright demonstrated this in a challenging project for a leading automotive manufacturer. The solution was implemented using Boston Micro Fabrication's (BMF) precision micro-stereolithography: Partner AM Pioneers in Esslingen 3D-prints high-precision connector plates for connectors in durable resin using a microArch S240 3D printer with 10 µm resolution.
Read More
CMM • July 3, 2025

Advancing Interposer Design for Next-Generation Microelectronics

As electronic systems become smaller, faster, and more functionally integrated, the packaging technologies that connect them must evolve. Traditional approaches like printed circuit boards, LTCC, and lithography-based fabrication often fall short when it comes to routing complex electrical pathways—especially in compact 3D architectures or between non-planar components.
Read More
Select Science • June 5, 2025

Micro-3D Printing Powers Cancer Organoid Research

Advances in cancer research increasingly depend on the ability to replicate the body's complex biology at a microscale. Join John Kawola, CEO of BMF, as he explores the role of 3D printing in organoid and cancer research.
Read More
Laboratory News • June 5, 2025

3D Printing in the Lab

The biomedical sector is emerging as a key arena for 3D printing technologies, enabling researchers to access new tools to tackle design challenges, explains Ricky Wildman.
Read More (page 36)
Endpoints News • April 11, 2025

Replacing Animal Testing with Organoids

Newly-installed FDA Commissioner Marty Makary announced a plan to begin phasing out animal testing in drug development, particularly for monoclonal antibodies, but how long will it take?
Read More